Negative emotions are jeopardising people managing their type 2 diabetes, according to new research. A quarter of people who use insulin to manage their condition feel anxious or fearful about ...
Innovation in diabetes care was showcased at the sixth annual QiC Diabetes awards. People working in the diabetes community were praised at the awards ceremony, which took place at Sanofi’s ...
A woman who had a hypo and passed out while driving on a motorway with her baby in the car was safely forced off the road by the police. PC Daniel Pattison responded to reports of a Peugeot ...
A combination of insulin glargine and lixisenatide helps people with type 2 diabetes reach meal-time blood sugar targets better, according to a new study. The LixiLan-L trial investigated a ...
Tarja Stenvall is the general manager for the Diabetes and Cardiovascular Business Unit and UK Country Chair for Sanofi. The pharmaceutical company has an 85-year commitment to improving the ...
A combination insulin/GLP-1 agonist drug has shown greater efficacy in controlling type 2 diabetes. The results of the Sanofi drug iGlarLixi, formerly known as LixiLan, were unveiled at ...
Teams who have “improved services and outcomes” for people with diabetes have just one week to enter the Quality in Care Diabetes (QiC) awards. The programme recognises, rewards and ...
Submissions for this year’s prestigious Quality in Diabetes Care (QiC) awards have opened. The announcement was made during the Diabetes UK Professional Conference in Glasgow where several ...
People who use Insuman pre-filled pens and cartridges have been warned of a temporary supply shortage of the products. Sanofi, the company which makes the items, said the limited availability ...
For nurses specialising in diabetes